NO20051896L - Farmasoytisk sammensetning som fast doseringsform samt fremgangsmate for fremstilling derav - Google Patents

Farmasoytisk sammensetning som fast doseringsform samt fremgangsmate for fremstilling derav

Info

Publication number
NO20051896L
NO20051896L NO20051896A NO20051896A NO20051896L NO 20051896 L NO20051896 L NO 20051896L NO 20051896 A NO20051896 A NO 20051896A NO 20051896 A NO20051896 A NO 20051896A NO 20051896 L NO20051896 L NO 20051896L
Authority
NO
Norway
Prior art keywords
pharmaceutical composition
dosage form
solid dosage
preparation
desmopressin
Prior art date
Application number
NO20051896A
Other languages
English (en)
Other versions
NO327328B1 (no
Inventor
Lars-Erik Olsson
Hakan Lomryd
Helena Nicklasson
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34117527&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20051896(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of NO20051896L publication Critical patent/NO20051896L/no
Publication of NO327328B1 publication Critical patent/NO327328B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20051896A 2003-07-25 2005-04-19 Farmasoytisk sammensetning som fast doseringsform samt fremgangsmate for fremstilling derav NO327328B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03016945A EP1500390B1 (en) 2003-07-25 2003-07-25 Pharmaceutical desmopressin composition as solid dosage form and method for manufacturing thereof
US10/626,857 US7022340B2 (en) 2003-07-25 2003-07-25 Pharmaceutical composition as solid dosage form and method for manufacturing thereof
PCT/EP2004/051538 WO2005011640A2 (en) 2003-07-25 2004-07-19 Pharmaceutical desmopressin composition as solid dosage form and method for manufacturing thereof

Publications (2)

Publication Number Publication Date
NO20051896L true NO20051896L (no) 2005-04-19
NO327328B1 NO327328B1 (no) 2009-06-08

Family

ID=34117527

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051896A NO327328B1 (no) 2003-07-25 2005-04-19 Farmasoytisk sammensetning som fast doseringsform samt fremgangsmate for fremstilling derav

Country Status (22)

Country Link
US (1) US7022340B2 (no)
EP (1) EP1500390B1 (no)
JP (1) JP4430673B2 (no)
KR (1) KR20050104331A (no)
AT (1) ATE301990T1 (no)
AU (1) AU2004260625B2 (no)
BR (1) BRPI0412905A (no)
CA (1) CA2490335C (no)
DE (1) DE60301351T2 (no)
DK (1) DK1500390T3 (no)
ES (1) ES2243840T3 (no)
HK (1) HK1072009A1 (no)
IL (1) IL187591A0 (no)
MX (1) MXPA06000903A (no)
NO (1) NO327328B1 (no)
NZ (1) NZ544104A (no)
PL (1) PL379704A1 (no)
PT (1) PT1500390E (no)
RU (1) RU2303439C2 (no)
SI (1) SI1500390T1 (no)
TW (1) TWI268782B (no)
WO (1) WO2005011640A2 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
US7094545B2 (en) * 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
CN1826099B (zh) * 2003-07-25 2010-06-09 凡林有限公司 固体剂型药物组合物及其制造方法
PT1530967E (pt) * 2003-11-13 2006-09-29 Ferring Bv Embalagem blister e uma forma de dosagem solida que compreende desmopressina.
CA2490601C (en) * 2003-12-29 2006-05-02 Ferring B.V. Method for preparing solid dosage form of desmopressin
US7018653B2 (en) * 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
SE528446C2 (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
ES2319054B1 (es) 2007-08-06 2010-02-12 Gp Pharm S.A. Composicion farmaceutica oral de desmopresina.
EP2197532A1 (en) 2007-08-06 2010-06-23 Serenity Pharmaceuticals Corporation Methods and devices for desmopressin drug delivery
US20090232896A1 (en) * 2008-03-11 2009-09-17 Mallinckrodt Inc. Use of Magnesium Stearate Dihydrate for Lubrication of Solid Pharmaceutical Compositions
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
WO2009143356A1 (en) * 2008-05-21 2009-11-26 Ferring International Center S.A. Orodispersible desmopressin for increasing initial period of sleep undisturbed by nocturia
CN102164989B (zh) * 2008-09-30 2013-11-27 三井化学株式会社 纤维增强树脂组合物及其成型体

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8306367L (sv) * 1983-11-18 1985-05-19 Ferring Ab Antidiuretiskt verkande farmaceutiskt preparat
US4675188A (en) * 1985-08-02 1987-06-23 Stauffer Chemical Company Granular anhydrous dicalcium phosphate compositions suitable for direct compression tableting
US4820627A (en) * 1986-03-24 1989-04-11 Em Diagnostic Systems, Inc. Method of preparing particles suitable for tabletting into diagnostic reagents
US5482931A (en) 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
AU1677095A (en) 1994-01-11 1995-08-01 Alkermes Controlled Therapeutics, Inc. Oral dosage form of desmopressin (ddavp)
SE9400918L (sv) 1994-03-18 1995-09-19 Anne Fjellstad Paulsen Stabiliserad komposition för oral administrering av peptider
US5849322A (en) 1995-10-23 1998-12-15 Theratech, Inc. Compositions and methods for buccal delivery of pharmaceutical agents
GB9526495D0 (en) 1995-12-23 1996-02-28 Knoll Ag Therapeutic agents
DE19602757A1 (de) * 1996-01-26 1997-07-31 Boehringer Mannheim Gmbh Feste Instant-Release-Darreichungsformen und Verfahren zu ihrer Herstellung
WO2000009423A1 (es) 1998-08-11 2000-02-24 Jaime Marti Sala Silo para almacenamiento de cuerpos huecos ligeros
AT409081B (de) 2000-02-16 2002-05-27 Gebro Pharma Gmbh Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung
GB0009469D0 (en) * 2000-04-17 2000-06-07 Vectura Ltd Improvements in or relating to formalities for use in inhaler devices
PE20011227A1 (es) * 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
NZ521972A (en) 2000-04-17 2004-06-25 Vectura Ltd Improvements in or relating to formulations for use in inhaler devices
GB0010709D0 (en) 2000-05-03 2000-06-28 Vectura Ltd Powders for use a in dry powder inhaler
CN100551358C (zh) 2000-06-27 2009-10-21 维克多瑞有限公司 用于药物组合物的颗粒的制备方法
SK1732004A3 (sk) 2001-10-15 2005-06-02 R�Hm Gmbh & Co. Kg Použitie kopolyméru na prípravu liekovej formy, ktorá ako účinnú látku obsahuje peptid alebo proteín
DE60307082T4 (de) 2002-05-07 2015-04-30 Ferring B.V. In der mundhöhle dispergierbare phamarzeutische zusammensetzung mit desmopressin
US7094545B2 (en) * 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
SI1473029T1 (en) * 2003-04-30 2005-10-31 Ferring B.V. Solid dosage form comprising desmopressin

Also Published As

Publication number Publication date
MXPA06000903A (es) 2006-05-04
BRPI0412905A (pt) 2006-09-26
US7022340B2 (en) 2006-04-04
ES2243840T3 (es) 2005-12-01
JP2007517762A (ja) 2007-07-05
EP1500390A1 (en) 2005-01-26
US20050019392A1 (en) 2005-01-27
WO2005011640A3 (en) 2005-03-24
TWI268782B (en) 2006-12-21
IL187591A0 (en) 2008-03-20
DE60301351D1 (de) 2005-09-22
NZ544104A (en) 2008-06-30
AU2004260625B2 (en) 2007-12-06
JP4430673B2 (ja) 2010-03-10
RU2303439C2 (ru) 2007-07-27
PL379704A1 (pl) 2006-11-13
HK1072009A1 (en) 2005-08-12
RU2005141230A (ru) 2006-07-10
ATE301990T1 (de) 2005-09-15
SI1500390T1 (sl) 2006-02-28
TW200509995A (en) 2005-03-16
WO2005011640A2 (en) 2005-02-10
PT1500390E (pt) 2005-10-31
DK1500390T3 (da) 2005-09-19
KR20050104331A (ko) 2005-11-02
DE60301351T2 (de) 2006-01-19
CA2490335A1 (en) 2005-01-25
EP1500390B1 (en) 2005-08-17
CA2490335C (en) 2006-01-31
NO327328B1 (no) 2009-06-08
AU2004260625A1 (en) 2005-02-10

Similar Documents

Publication Publication Date Title
NO20051896L (no) Farmasoytisk sammensetning som fast doseringsform samt fremgangsmate for fremstilling derav
MY148680A (en) Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
MY148773A (en) Galenic formulations of organic compounds
DE60104399D1 (de) Pulverformulierung zur inhalation
WO2003082853A8 (en) New compounds
EA200401583A1 (ru) Таблетка лазофоксифена и ее покрытие
MY138734A (en) Casr antagonist
EA200301040A1 (ru) Способ производства фармацевтической композиции низкой дозы
ATE329581T1 (de) Pharmazeutische formulierung, die n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydr -2h-(1, 3)oxazino(3,2-a)indol-10-carboxamid oder ein entsprechendes salz hiervon enthält, sowie deren herstellungsprozess, welcher trockengranulierung beinhaltet
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
SE0102440D0 (sv) New compound
AR046226A1 (es) Formulaciones farmaceuticas que contienen saborizante con caracteristicas farmaceuticas mejoradas
NO331205B1 (no) Farmasoytisk sammensetning som fast doseringsform og fremgangsmate for fremstilling derav
BE2016C017I2 (no)
SE0000303D0 (sv) Novel compounds
IL163025A (en) Prucalopride - n - oxides, their preparation and pharmaceutical compositions comprising them
EA200401082A1 (ru) Новые соединения бензоиндолина, способ их получения и фармацевтические композиции, которые их содержат
AR046261A1 (es) Composicion farmaceutica como forma de dosificacion solida y metodo para su fabricacion
HRP20110563T1 (en) Salt of 4[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees